Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Sands BE, D'Haens G, Clemow DB, Irving PM, Johns JT, Gibble TH, Abreu MT, Lee SD, Hisamatsu T, Kobayashi T, Dubinsky MC, Vermeire S, Siegel CA, Peyrin-Biroulet L, Moses RE, Milata J, Panaccione R, Dignass A. Sands BE, et al. Among authors: dubinsky mc. Inflamm Bowel Dis. 2024 Oct 25:izae253. doi: 10.1093/ibd/izae253. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 39448057
A pilot study of adalimumab in infliximab-allergic patients.
Youdim A, Vasiliauskas EA, Targan SR, Papadakis KA, Ippoliti A, Dubinsky MC, Lechago J, Paavola J, Loane J, Lee SK, Gaiennie J, Smith K, Do J, Abreu MT. Youdim A, et al. Among authors: dubinsky mc. Inflamm Bowel Dis. 2004 Jul;10(4):333-8. doi: 10.1097/00054725-200407000-00002. Inflamm Bowel Dis. 2004. PMID: 15475739 Clinical Trial.
Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease.
Spivak J, Landers CJ, Vasiliauskas EA, Abreu MT, Dubinsky MC, Papadakis KA, Ippoliti A, Targan SR, Fleshner PR. Spivak J, et al. Among authors: dubinsky mc. Inflamm Bowel Dis. 2006 Dec;12(12):1122-30. doi: 10.1097/01.mib.0000235833.47423.d7. Inflamm Bowel Dis. 2006. PMID: 17119386 Clinical Trial.
Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease.
Siegel CA, Siegel LS, Hyams JS, Kugathasan S, Markowitz J, Rosh JR, Leleiko N, Mack DR, Crandall W, Evans J, Keljo DJ, Otley AR, Oliva-Hemker M, Farrior S, Langton CR, Wrobel IT, Wahbeh G, Quiros JA, Silber G, Bahar RJ, Sands BE, Dubinsky MC. Siegel CA, et al. Among authors: dubinsky mc. Inflamm Bowel Dis. 2011 Jan;17(1):30-8. doi: 10.1002/ibd.21386. Epub 2010 Sep 1. Inflamm Bowel Dis. 2011. PMID: 20812335 Free PMC article.
343 results